BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6956209)

  • 21. Evaluation of cerebrospinal fluid mononuclear cells obtained from children with acute lymphocytic leukemia: advantages of combining cytomorphology and terminal deoxynucleotidyl transferase.
    Casper JT; Lauer SJ; Kirchner PA; Gottschall JL; Camitta BM
    Am J Clin Pathol; 1983 Nov; 80(5):666-70. PubMed ID: 6579834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the expression of terminal deoxynucleotidyl transferase and common acute lymphoblastic leukemia antigen in selected hematologic malignancies.
    Bodner SM; Casavant CH; McHugh TM; Stites DP
    Diagn Immunol; 1985; 3(3):139-44. PubMed ID: 2932276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural, cytochemical and surface marker analysis of cells during blast crisis of chronic granulocytic leukaemia.
    Catovsky D; O'Brien M; Cherchi M; Benavides I
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):344-54. PubMed ID: 282904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marrow terminal deoxynucleotidyl transferase activity in adult acute leukemia.
    Wiernik PH; Edwards LS; Sarin PS
    Haematol Blood Transfus; 1979; 23():125-30. PubMed ID: 296107
    [No Abstract]   [Full Text] [Related]  

  • 25. [Preliminary studies of the enzymologic properties of terminal deoxynucleotidyl transferase and its clinical application].
    Li M; Sun ZL; Lei YD; Zhou Q; Ruan HF; Wu JX
    Hua Xi Yi Ke Da Xue Xue Bao; 1986 Sep; 17(3):176-9. PubMed ID: 3470249
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical utility of initial terminal deoxynucleotidyl transferase determinations in childhood acute leukemias.
    Kalwinsky DK; Weatherred WH; Dahl GV; Bowman WP; Melvin SL; Coleman MS; Bollum FJ
    Cancer Res; 1981 Jul; 41(7):2877-81. PubMed ID: 7018672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The kinetics of terminal deoxynucleotidyl transferase-positive cells in the mixed colony assay.
    Bodger MP; LeBien TW
    Int J Cell Cloning; 1986 Sep; 4(5):312-9. PubMed ID: 3534109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
    Morse EE; Gaffney J; Donskoy E; Pisciotto P; Altman A; Quinn J; Goldschneider I
    Ann Clin Lab Sci; 1983; 13(2):128-32. PubMed ID: 6344744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enrichment of terminal deoxynucleotidyl transferase activity by cell separation.
    Sarin PS; Virmani M; Gallo RC
    Adv Exp Med Biol; 1982; 145():337-56. PubMed ID: 6981292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terminal deoxynucleotidyl transferase (TdT) and membrane receptors in human leukemia and lymphoma -- first experience with lyophilized cells.
    Wetter O; Hossfeld DK; Linder KH; Brandhorst D
    Klin Wochenschr; 1981 Apr; 59(8):365-75. PubMed ID: 6945460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid receptors and terminal deoxynucleotidyl transferase activities in leukemic cells.
    Nakao Y; Tsuboi S; Fujita T; Masaoka T; Morikawa S; Watanabe S
    Cancer; 1981 Apr; 47(7):1812-7. PubMed ID: 6971704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of TdT positivity in cases of leukemia and lymphoma.
    Drexler HG; Menon M; Minowada J
    Acta Haematol; 1986; 75(1):12-7. PubMed ID: 3088880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terminal transferase in leukemias by flow cytometry.
    Loftin KC; Reuben JM; Dalton W; Hersh EM; Sujansky D
    Diagn Immunol; 1986; 4(3):165-9. PubMed ID: 3460728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disappearance of nuclear TdT in RPMI-8402 following TPA treatment.
    Sacchi N; Bertazzoni U; Breviario D; Plevani P; Badaracco G; Ginelli E
    Adv Exp Med Biol; 1982; 145():177-83. PubMed ID: 7051778
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of terminal deoxynucleotidyl transferase in malignant myeloblasts.
    Bradstock KF; Hewson J; Kerr A; Kabral A; Lee CH; Hughes WG
    Am J Clin Pathol; 1983 Dec; 80(6):800-5. PubMed ID: 6314803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic changes during blast crisis of CML characterized by occurrence and loss of TDT.
    Paietta E; Schwarzmeier JD
    Adv Exp Med Biol; 1982; 145():331-6. PubMed ID: 6956208
    [No Abstract]   [Full Text] [Related]  

  • 37. Nuclear terminal deoxynucleotidyl transferase in leukaemic infiltrates of testicular tissue.
    Thomas JA; Janossy G; Eden OB; Bollum FJ
    Br J Cancer; 1982 May; 45(5):709-17. PubMed ID: 7044402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of terminal deoxynucleotidyl transferase as prognosticator in leukemia patients.
    Bhatavdekar JM; Trivedi SN; Vora HH; Shukla SN
    Int J Biol Markers; 1993; 8(2):77-80. PubMed ID: 8366299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous evaluation of terminal deoxynucleotidyl transferase and myeloperoxidase in acute leukemias using an immunocytochemical method.
    Kaplan SS; Penchansky L; Krause JR; Basford RE; Zdziarski U
    Am J Clin Pathol; 1987 Jun; 87(6):732-8. PubMed ID: 3035914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disappearance of terminal deoxynucleotidyltransferase in human malignant T-lymphoblasts treated with a human alpha interferon preparation.
    Takano S; Nakamura H; Mita H; Nagano Y
    Microbiol Immunol; 1984; 28(10):1111-5. PubMed ID: 6335218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.